Breast Lesions Characterization on Contrast Enhanced Ultrasound With Histopathological Correlation

Trial Profile

Breast Lesions Characterization on Contrast Enhanced Ultrasound With Histopathological Correlation

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Sulfur hexafluoride (Primary)
  • Indications Breast cancer
  • Focus Diagnostic use
  • Most Recent Events

    • 03 Oct 2014 Planned end date changed from 1 Jul 2015 to 1 Oct 2015,according to ClinicalTrials.gov record.
    • 03 Oct 2014 Planned primary completion date changed from 1 Jul 2015 to 1 Oct 2015, according to ClinicalTrials.gov record.
    • 03 Oct 2014 Planned initiation date changed from 1 Jul 2014 to 1 Oct 2014, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top